BrainCheck is a computerized cognitive assessment aid that rovides rapid, mobile cognitive assessment and decision support technology to physicians, empowering them to deliver high-quality, personalized cognitive health care to patients everywhere and get reimbursed.
BrainCheck’s mission is to help physicians deliver the highest quality, person-centered cognitive care, and to help people of all ages understand what’s happening in their brain.
BrainCheck was founded in 2014 by Yael Katz and David Eagleman. The company is headquartered in Houston, Texas.
BrainCheck helps lessen the human and economic toll of cognitive impairment and dementia through its interactive cognitive assessment and care management technology.
BrainCheck is used in over 400 clinical practices and by 150,000 people around the world to detect cognitive changes early and enable patients, caregivers, and clinicians to work together to implement personalized recommendations to preserve brain health and functional independence.
BrainCheck enables physicians to get paid for cognitive care management (via Medicare reimbursement and risk-adjusted capitated payments) and simultaneously reduces healthcare costs by keeping patients healthy, safe, and out of the hospital.
BrainCheck is backed by Next Coast Ventures, S3 Ventures, Tensility Venture Partners, True Wealth Ventures, Nueterra Capital, UPMC Enterprises, and others. The company raised $10M in Series B round on Nov 03, 2021. This brings BrainCheck's total funding to $24.7M to date.